Riskpilot← Back to searchSign inGet full accessMedico Investment nr. 2 Komplementar ApS
APSActiveCVR 40530738Tesch Alle 3Activities of holding companies · NACE 6421Est. 2019— employees
Revenue 2024
DKK -11K
-7% vs 2023
EBITDA margin
100.0%
+7% vs 2023
Equity ratio
13.2%
Financial strength
Net profit 2024
DKK -16K
-27% vs 2023
| Revenue | DKK -11K | -7% |
| EBITDA | DKK -11K | +7% |
| Net profit | DKK -16K | -27% |
| Total assets | DKK 73K | -16% |
| Equity | DKK 10K | -63% |
| Employees | — | — |
Legal name
Medico Investment nr. 2 Komplementar ApS
CVR number
40530738
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
20. maj 2019
Share capital
DKK 55.561
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør.
Company purpose
Selskabets formål er at være komplementar og udgøre ledelsen i selskabet K/S Medico Investment nr. 2.
Address
Tesch Alle 3
Phone
+4540149113
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -4 | -4 | -4 | -12 | -11 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -4 | -4 | -4 | -12 | -11 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -4 | -4 | -4 | -12 | -11 |
| Net financials | 0 | 0 | 0 | -1 | -6 |
| Profit before tax | -4 | -4 | -4 | -13 | -16 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -4 | -4 | -4 | -13 | -16 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 52 | 48 | 48 | 87 | 73 |
| Equity | 48 | 43 | 39 | 26 | 10 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4 | 4 | 8 | 61 | 63 |
| Total debt | 4 | 4 | 8 | 61 | 63 |
EBITDA margin
-1071400.0%
This company
15.8%
Market median
-6781113% vs market
20202024
Equity ratio
13.2%
This company
38.2%
Market median
-65% vs market
20202024
Return on equity
-171.7%
This company
18.4%
Market median
-1033% vs market
20202024
Net profit margin
-1649500.0%
This company
8.1%
Market median
-20364298% vs market
20202024
Asset turnover
-0.15×
This company
1.12×
Market median
-113% vs market
20202024
Debt / equity
6.57×
This company
0.62×
Market median
-960% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
HH Chief Executive Officer | Chief Executive Officer | 2019 |
AC Founder | Founder | 2019 |
HK Founder | Founder | 2019 |
KR Founder | Founder | 2019 |
KP Founder | Founder | 2019 |
JX Founder | Founder | 2019 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 20–24.99% | 20–24.99% | 2021 | |
| Company | 10–14.99% | 10–14.99% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CKM HOLDING AF 28.07.11 ApS
Medico Investment nr. 2 Komplementar ApS Board members of Medico Investment nr. 2 Komplementar ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Harboe | Chief Executive Officer | 0 companies |
| Anne Camilla Münter | Founder | 0 companies |
| Henning Kristensen | Founder | 0 companies |
| Karin Rasmussen | Founder | 0 companies |
| Knud Prytz | Founder | 0 companies |
| Jackpot X Ltd | Founder | 0 companies |